Skip to main content
. 2022 Jun 16;106:103768. doi: 10.1016/j.drugpo.2022.103768

Table 1.

Results of the round 1 and round 2 Delphi process.

Round One
Steering group consensus Round Two
Final recommendations
Clinical Domain Total Accepted Revision* Rejected New statements included Total Accepted Rejected Total accepted
Assessment 8 6 2 0 1 3 3 0 9
OAT drug choice and optimal dosing 5 2 3 0 1 4 1 3 3
Drug testing 2 0 2 0 0 2 0 2 0
Take-away doses 1 1 0 0 0 0 0 0 1
Overdose prevention 2 2 0 0 0 0 0 0 2
E-Prescriptions 1 1 0 0 0 0 0 0 1
Total 19 12 7 0 2 9 4 5 16

Required revision, rewording or refinement.

The project steering group developed new statements to be included in round two based on comments/suggestions made by panel members during the first round.

Where consensus was not reached at round two, statements were rejected.